Tilray Brands Inc (TLRY)

NASDAQHealthcare

$8.68
-$0.05 (-0.7%)
Last close

January 21, 2026 at 21:00 UTC

Interactive Chart
TLRY
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Tilray Brands Inc

Name

Tilray Brands Inc

CEO

Irwin David Simon

Industry

Healthcare

Year Founded

2013

Employees

2,650

Tilray Brands Inc is a cannabis and consumer packaged goods company that treats cultivation, processing, and market entry as parts of one governed system. The business runs controlled facilities, enforces standard work in post-harvest and release, and communicates dosage and storage in terms that satisfy retail, medical, and export requirements. Tilray integrates brand craft with compliance by sizing promotions to what age-gated channels and regulators can support, avoiding theatrics that do not survive inspection. International work proceeds through partnerships and country teams that understand local frameworks, with shipments staged after documentation and distribution are in place. The company frames cannabis as a category that must be managed like any other regulated product: measured launches, traceable lots, and labeling that reads the same to consumers, clinicians, and authorities.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 4 Buy, 8 Hold, 9 Sell
Buy4
Hold8
Sell9
Fundamentals & Financials
Revenue (TTM)
$1.1B
Net Income (TTM)
$-2.9B
EPS (TTM)
$-30.81
ROA (TTM)
-100.62%
Current Ratio
2.81
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ4 2025
Revenue$303,852.9K
Cost of Sales$223,530.7K
Gross Profit$80,322.1K
Operating Income$-31,123.3K
Net Income$-62,767.7K
EPS$-0.41
Technical Indicators

Tilray Brands Inc's Technical Indicators Summary

TLRY’s technical indicators suggest a neutral outlook as momentum measures like RSI and CCI hover near midrange, indicating neither strong buying nor selling pressure, while the MACD remains subdued. The trend strength, reflected by a modest ADX below 20, points to a lack of directional conviction. Price sits close to its short-term moving averages, with a buy signal from the 10-day SMA but sell signals from most medium-term averages, contrasting with supportive levels from the 200-day averages. Volatility remains elevated with ATR showing notable price swings, and volume trends are positive as OBV indicates accumulation. Overall, these mixed signals contribute to a balanced technical stance without clear bias.

Buy
4 signals
Neutral
8 signals
Sell
9 signals
Overall: Neutral38% Neutral signals
IndicatorValue
RSI (14)
47.25
Stochastic %K (14, 3, 3)
58.82
CCI (20)
-35.75
WPR (14)
-50.00
Momentum (10)
-0.26
MFI
41.18
MACD Level (12, 26)
-0.21
Bollinger Bands
$8.08 - $11.42
ATR (14)
$0.88 (9.28%)
ADX (14)
18.89
OBV
6,391,340
Simple Moving Averages
$8.86 - $12.01(5 indicators)
Exponential Moving Averages
$9.05 - $10.50(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The day begins with an unusually bullish tilt in TLRY options, reflected in a put/call ratio of 0.13. Morning liquidity is scarce: TLRY is seeing just 0.15× its usual early turnover. Market gains amid Tilray's record Q2 revenue and reduced losses, boosting investor optimism.

Price Change

from $8.75 close

+$0.06

Trading Volume

Below avg (7.2M)

1.1M

vs S&P 500 Today

Underperforming Market

-0.80%

52-Week Position

Lower range

27%

Updated: January 21, 2026 at 15:35 UTC

Quote Summary
OpenPrevious Close
$8.75$8.75
Day Range52 Week Range
$8.61 - $8.97$3.5 - $23.2
VolumeAvg. Volume
3.2M10.3M
Market CapP/E Ratio
$889.8M40.6